Impact of manual thrombectomy on microvascular obstruction in STEMI patients.
Journal article

Impact of manual thrombectomy on microvascular obstruction in STEMI patients.

  • Meier D Department of Cardiology, Lausanne University Hospital, Lausanne, Switzerland.
  • Fournier S Department of Cardiology, Lausanne University Hospital, Lausanne, Switzerland.
  • Masci PG Department of Cardiology, Lausanne University Hospital, Lausanne, Switzerland.
  • Eeckhout E Department of Cardiology, Lausanne University Hospital, Lausanne, Switzerland.
  • Antiochos P Department of Cardiology, Lausanne University Hospital, Lausanne, Switzerland.
  • Tzimas G Department of Cardiology, Lausanne University Hospital, Lausanne, Switzerland.
  • Stoyanov N Department of Cardiology, Lausanne University Hospital, Lausanne, Switzerland.
  • Muenkaew M Department of Cardiology, Lausanne University Hospital, Lausanne, Switzerland.
  • Monney P Department of Cardiology, Lausanne University Hospital, Lausanne, Switzerland.
  • Schwitter J Department of Cardiology, Lausanne University Hospital, Lausanne, Switzerland.
  • Muller O Department of Cardiology, Lausanne University Hospital, Lausanne, Switzerland.
  • Harbaoui B Department of Cardiology, Lausanne University Hospital, Lausanne, Switzerland.
Show more…
  • 2020-04-12
Published in:
  • Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. - 2020
English OBJECTIVE
To assess the effect of manual thrombectomy (MT) on microvascular obstruction (MVO) using cardiac magnetic resonance (CMR) in ST-segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI).


METHODS AND RESULTS
Three hundred and eighty-three patients admitted for STEMI and undergoing CMR fulfilled the inclusion criteria and were categorized into two groups (did or did not undergo MT). The two primary endpoints were the occurrence and extent of MVO, analyzed as a categorical variable and as a semicontinuous variable. Among the 383 patients, 49.1% exhibited MVO. Both the incidence of MVO and the median number of segments presenting with MVO were significantly higher in the MT group than in the no-MT group, (59.5 vs. 38.9%, p < .001) and (1.5 [0;4] vs. 0 [0;2], p < .001). Analysis stratified on coronary thrombus grade showed similar results, only in patients with a high thrombus burden (60.7 vs. 43.5%, p = .004, and 2 [0;4] vs. 0 [0;3], p = .001). When adjusting for baseline differences, MT remained a determinant of MVO occurrence and extent (odds ratio, OR 1.802 [95% confidence interval, CI 1.080-3.009], p = .024) and β = .137, p = .024) in patients with a high thrombus grade.


CONCLUSION
In STEMI patients, MT was associated with the occurrence and extent of MVO, on CMR, especially in patients with a high thrombus burden.
Language
  • English
Open access status
closed
Identifiers
Persistent URL
https://folia.unifr.ch/global/documents/78169
Statistics

Document views: 13 File downloads: